Testosterone Lawsuit

Testosterone Therapy Heart Attack & Stroke

Seeger Weiss served as trial counsel in the first three bellwether trials representing plaintiffs who suffered heart attack or stroke after using the prescription testosterone topical product Androgel, which resulted in more than $290 million in initial verdicts.


Prior results do not guarantee or predict a similar outcome in any future matter.

Our Role

Seeger Weiss founding partner Chris Seeger served as co-lead counsel in litigation against AbbVie Inc. and other manufacturers, concerning major adverse medical events caused by their testosterone replacement therapy products. In addition, Seeger Weiss partner Dave Buchanan served as trial counsel in first three bellwether trials in this multidistrict litigation, which resulted in more than $290 million in initial verdicts for two plaintiffs who suffered heart attacks following use of testosterone-replacement product AndroGel.